CIK 0001356090 · Non-accelerated filer<br>Smaller reporting company
PRECIGEN, INC.
Sign in to watch- Ticker
- PGEN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- Phone
- 301-556-9900
- Business address
- 20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD, 20876
- Former names
- INTREXON CORP
- 144 Insider Sale of Securities
- 4 Open-market buy Chief Operating Officer bought 2,000 shares at $3.40 ($6,800)
- 4 Open-market buy Chief Commercial Officer bought 6,000 shares at $3.58 ($21,480)
- 144 Insider Sale of Securities
- 4 Open-market buy Chief Financial Officer bought 11,216 shares at an average $3.57 ($40,016)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- EFFECT Other Notice of Effectiveness
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale Director sold 5,000,252 shares at an average $3.73 ($18,653,532)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Unregistered share sale
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 15,000 shares at $4.60 ($69,000)
- 8-K Event Material agreement · New debt or obligation · Regulation FD disclosure
Page 6 of 67 · 1,325 filings